ISS Collaboration - Singleron Biotechnologies GmbH joined the pursuit of "Reaching for the Stars"
28 Apr 2023
MSIDA, Malta, April 28, 2023 /PRNewswire/ -- Yesterday, the celebrations for the MALETH project took place with a special keynote presentation from Dr. James Green, NASA's Former Chief Scientist. From Singleron, Dr. Samuel Kerr joined to present the yeast research studies aboard the International Space Station.
The MALETH Project, which was led by Professor Joseph Borg from the University of Malta brought internationally excelling scientists together to analyze samples of human skin tissue and yeast cells that were sent into space to understand how the conditions of the harsh environment in space and at the International Space Station ISS affected the samples.
Professor Borg commented: "This international collaboration, to which Singleron contributed with their expertise on single cell analysis, is opening the window into profiling the microbiome in the context of space and the microgravity environment. Collectively, we are improving precision medicine and overall research in life and health sciences. Looking forward to more exciting projects that allow us to look and even reach the stars yet with feet on the ground to deliver applied science where it matters most."
This is where the scientist, who feels at home in space, speaks our mind: "Enhancing health and quality of life is our mission at Singleron! We were very proud to join this project and thankful for the opportunity!", concludes Dr. Bruno Monschau, GM at Singleron Biotechnologies GmbH.
About Singleron:
Founded in 2018, Singleron develops and commercializes single cell multi-omics products that can be used in both research and clinical settings. Its current product portfolio includes instruments, microfluidic devices, reagents, software analysis and database solutions that facilitate high-throughput single cell analysis. Singleron's sample services offer expert execution and generation of high-quality results for academia, clinics, and biotech.
The company currently has offices, laboratories, and manufacturing facilities in Germany, Singapore, China, and the US. Its products are used in over 2,000 laboratories in hospitals, research institutes, and pharmaceutical companies.
Public Relations Contact:
Email: [email protected]
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.